NEXTHERA CAPITAL LP - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
NEXTHERA CAPITAL LP ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$995,000
-61.1%
42,865
-64.8%
1.21%
+14.4%
Q4 2018$2,559,000
+115.8%
121,892
+298.1%
1.06%
+364.8%
Q3 2018$1,186,000
-76.8%
30,622
-76.4%
0.23%
-71.3%
Q2 2018$5,108,000129,8000.79%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders